Silvio Sosa

Prof. Silvio Sosa

Life Sciences, University of Trieste, Trieste, Friuli-Venezia Giulia, Italy
orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2001 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
DBDea Baričevič
Dea Baričevič
SSSilvio Sosa
Silvio Sosa
RLR. Della Loggia
R. Della Loggia
ATA. Tubaro
A. Tubaro
BSB. Simonovska
B. Simonovska
AZA. Zupancic
A. Zupancic

1 February 2008 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
Filomena ConfortiFilomena Conforti
Filomena Conforti
SSSilvio Sosa
Silvio Sosa
Mariangela MarrelliMariangela Marrelli
Mariangela Marrelli
FMFederica Menichini
Federica Menichini
GSGiancarlo Statti
Giancarlo Statti
RLRoberto Della Loggia
Roberto Della Loggia

1 March 2011 in Toxicon
Verified
Journal Article
Closed access
Aurelia TubaroAurelia Tubaro
Aurelia Tubaro
PDP. Durando
P. Durando
GFG. Del Favero
G. Del Favero
FAF. Ansaldi
F. Ansaldi
GIG. Icardi
G. Icardi
SSSilvio Sosa
Silvio Sosa

12 January 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MPMarco Pelin
Marco Pelin
LFLaura Fusco
Laura Fusco
VLVerónica León
Verónica León
Cristina MartínCristina Martín
Cristina Martín
Alejandro CriadoAlejandro Criado
Alejandro Criado
MPMaurizio Prato
Maurizio Prato
Impressive properties make graphene-based materials (GBMs) promising tools for nanoelectronics and biomedicine. However, safety concerns need to be cleared before mass production of GBMs starts. As skin, together with lungs, displays the highest exposure to GBMs, it is of fundamental importance to understand what happens when GBMs get in contact with skin cells. The present study was carried out on HaCaT keratinocytes, an in vitro model of skin toxicity, on which the effects of four GBMs were evaluated: a few layer graphene, prepared by ball-milling treatment (FLG), and three samples of graphene oxide (GOs, a research-grade GO1, and two commercial GOs, GO2 and GO3). Even though no significant effects were observed after 24 h, after 72 h the less oxidized compound (FLG) was the less cytotoxic, inducing mitochondrial and plasma-membrane damages with EC50s of 62.8 μg/mL (WST-8 assay) and 45.5 μg/mL (propidium iodide uptake), respectively. By contrast, the largest and most oxidized compound, GO3, was the most cytotoxic, inducing mitochondrial and plasma-membrane damages with EC50s of 5.4 and 2.9 μg/mL, respectively. These results suggest that only high concentrations and long exposure times to FLG and GOs could impair mitochondrial activity associated with plasma membrane damage, suggesting low cytotoxic effects at the skin level.

1 June 2003 in Toxicon
Verified
Journal Article
Closed access
ATA Tubaro
A Tubaro
SSSilvio Sosa
Silvio Sosa
MCM Carbonatto
M Carbonatto
GAG Altinier
G Altinier
FVF Vita
F Vita
TYT Yasumoto
T Yasumoto

1 December 1994 in Planta Medica
Verified
Journal Article
Closed access
PDF file
RLR. Loggia
R. Loggia
ATA. Tubaro
A. Tubaro
SSSilvio Sosa
Silvio Sosa
HBH. Becker
H. Becker
SSSt. Saar
St. Saar
OIO. Isaac
O. Isaac
By means of a bioassay-oriented fractionation of the CO2 extract of Calendula flowers, the triterpenoids are shown as the most important anti-inflammatory principles of the drug. Among them, the faradiol monoester appears to be the most relevant principle for the activity of the drug, due to its quantitative prevalence. The unesterified faradiol, not present in the extract, is the most active of the tested compounds and equals indomethacin in activity, whereas the monools ψ-taraxasterol, lupeol, taraxasterol, and β-amyrin are less active than the free diol. The anti-inflammatory activity of different CO2 extracts is proportional to their content of faradiol monoester, which can be taken as a suitable parameter for the quality control of Calendula preparations.